Citius Pharmaceuticals, Inc.
CTXR · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $13,721 | $145,113 | $166,680 | $294,600 |
| - Cash | $4,252 | $3,252 | $26,481 | $41,712 |
| + Debt | $813 | $263 | $481 | $678 |
| Enterprise Value | $10,282 | $142,124 | $140,680 | $253,566 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$214 | -$210 | -$194 | -$180 |
| % Margin | – | – | – | – |
| EBITDA | -$38,201 | -$38,640 | -$31,773 | -$32,885 |
| % Margin | – | – | – | – |
| Net Income | -$37,434 | -$39,139 | -$32,543 | -$33,641 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.38 | -5.97 | -5.57 | -5.76 |
| % Growth | 43.4% | -7.2% | 3.3% | – |
| Operating Cash Flow | -$26,553 | -$28,201 | -$29,060 | -$28,361 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$26,553 | -$28,201 | -$29,060 | -$28,361 |